ArticleTranslational cancer research2021

RCHOP-14 therapy versus RCHOP-21 therapy for people with aggressive or advanced-stage indolent B-cell non-Hodgkins lymphoma: a systematic review and meta-analysis.

Yue He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.